Health Portugal Brokerage Event 2024

14–18 Oct 2024 | Porto, Portugal

Luis Valente

CEO & Co-Founder

iLoF

Porto, Portugal

14 profile visitsFull Conference - HCP Member

Business manager, strategist, and entrepreneur with a drive for using innovative and creative strategies to solve complex problems. Forbes 30U30.

My organisation

iLoF

iLoF

SME/ Start-up

Porto, Portugal

iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development. Through advanced AI and Photonics, iLoF is collecting massive amounts of data to build a digital library of biomarkers and biological profiles, bringing together world-class physicists, biologists, and data scientists to get life-saving personalized treatments to patients faster. Recognized by CB Insights as one of the top Digital Health companies in the world and by the Financial Times as a Transformational Business in Healthcare, iLoF is supported by leading institutions like Microsoft Ventures, Mayfield or the Oxford University, and has been regularly featured by outlets like Tech Crunch, Wired, or Sifted as a rising star in AI-Driven Drug Discovery, Health Screening & Data Analytics.
Read more

About me

Business manager, strategist, and entrepreneur with a drive for using innovative and creative strategies to solve complex problems.

Forbes 30 under 30 for Science and Healthcare, with a background in Computer Science, I have spent several years focusing on innovation and improving strategies in companies from Tech to Healthcare.

My passion for entrepreneurship led me to create my first business at 18, founding and operating several ventures specializing in optimized demand prediction, lean operations, and design for growth.

A deep belief in the power of Technology as the core driver for democratizing Personalized Medicine had me co-founding iLoF: a fast-growing deep tech company using AI to build a cloud-based library of disease biomarkers and biological profiles.

Currently on a mission to accelerate adequate treatments for millions of patients living with complex, heterogeneous diseases around the globe.

My organisation

iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development.

Through advanced AI and Photonics, iLoF is collecting massive amounts of data to build a digital library of biomarkers and biological profiles, bringing together world-class physicists, biologists, and data scientists to get life-saving personalized treatments to patients faster.

Recognized by CB Insights as one of the top Digital Health companies in the world and by the Financial Times as a Transformational Business in Healthcare, iLoF is supported by leading institutions like Microsoft Ventures, Mayfield or the Oxford University, and has been regularly featured by outlets like Tech Crunch, Wired, or Sifted as a rising star in AI-Driven Drug Discovery, Health Screening & Data Analytics.

Social media